Question 1

What are the specific benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women clinical trial (NCT02914158). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the side effects of the treatments in this trial compare to what I might experience with standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women clinical trial (NCT02914158). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women clinical trial (NCT02914158). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for treatment and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women clinical trial (NCT02914158). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women clinical trial (NCT02914158). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women clinical trial (NCT02914158). Contact the study team or your healthcare provider for specific answers.

What this study is about